Tricuspid Valve Repair Using Minimally Invasive Catheter
Part of Heart & circulation clinical trials.
This study tests a new catheter-based device (inserted through a vein, not open surgery) to repair a leaky tricuspid heart valve in patients who remain symptomatic despite taking medications. The goal is to improve heart function and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe tricuspid regurgitation (a leaky heart valve) that causes symptoms even with optimal heart medications
- Your heart team has determined you are a good candidate for this catheter-based repair procedure
- You do not currently have any tricuspid valve device in place
- Your heart's pumping function (left ventricular ejection fraction) is at least 25%
- Your doctors expect you to live at least 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial tests a new robotic catheter procedure to repair a leaky tricuspid valve (the valve on the right side of your heart). Instead of open-heart surgery, doctors thread a tiny device through a vein in your neck to fix the valve. It may be an option if you have severe leaking and your heart team thinks surgery is too risky for you.
This study tracks patients with weak heart pumps and leaky tricuspid valves (a valve on the right side of the heart) who receive a minimally invasive repair procedure. The goal is to understand how this treatment affects patients' heart function and quality of life over time.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial studies a minimally invasive “edge-to-edge” clip procedure to reduce severe leakage of the tricuspid valve. It’s for people who still feel unwell despite standard treatments and may be too high-risk for open-heart surgery.
This trial tests a new device that replaces a leaky tricuspid valve (a heart valve) without open-heart surgery. If your tricuspid valve isn't working well and medicines haven't helped enough, this procedure might improve your heart function and symptoms.
Hear when a new Tricuspid Regurgitation (TR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.